Exchange: NYSE·Updated 04:01 AM EDT
Latest Earnings Results: Q2 '26

Reported: Jul 23

Estimated EPS

$0.74

Reported EPS

$0.78

Surprise

+4.97%

Estimated Rev

$1.7B

Reported Rev

$1.74B

Surprise

+2.4%

$EW Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.42 down -26.32% YoY • Reported revenue of $1.74B up 13.63% YoY • Edwards Lifesciences projects 2026 full-year sales growth of 10% to 11% and reaffirms adjusted EPS guidance of $2.95 to $3.05, while expecting Q3 2026 sales between $1.63 and $1.71 billion.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.74
--
--
N/A
Q2 '26
$0.74
$0.78
4.97%
BEAT
Q1 '26
$0.73
$0.78
6.98%
BEAT
Q4 '25
$0.62
$0.58
-6.36%
MISSED
Q3 '25
$0.60
$0.67
12.39%
BEAT

Advertisement|Remove ads.